The Division of Hematology/Oncology is an integral part of the University of Pittsburgh Cancer Institute (UPCI) and emphasizes clinical care, research, and teaching. Programs within the Division include clinical research in solid tumor oncology, hematological malignancies, clinical hematology, hematopoietic stem cell transplantation, and thrombosis/hemostasis.
The facilities of the Division include a well-respected bone marrow transplant unit, fully staffed Hematology/Oncology outpatient clinics in UPCI for administration of cancer therapies to outpatients also serving as a major site for clinical research and therapeutic trials, and an outstanding inpatient unit at UPMC Shadyside. In addition to the onsite patient care programs, the Division maintains a network of oncologists and hematologists who assist in the conduct of its numerous clinical trials. Central to this network is Hematology/Oncology Associates, a 17-member group acquired by the UPMC Health System over the past several years, and the 25-member Oncology Hematology Associates group. These cadres of physicians articulate the Hematology/Oncology program of the UPMC Health System throughout the geographic area of the region.